98%
921
2 minutes
20
The incidence of candidemia by the complex has increased considerably in recent decades, frequently related to use of indwelling intravascular catheters. The ability of this pathogen to colonize healthcare workers (HCW)' hands, and to form biofilm on medical devices has been associated with the occurrence of nosocomial outbreaks and high mortality rates. Fluconazole has been the leading antifungal drug for the treatment of invasive candidiasis in developing countries. However, azole-resistant isolates are emerging worldwide, including in Brazil. Few studies have correlated outbreak infections due to with virulence factors, such as biofilm production. We thus conducted a microbiological investigation of complex isolates from a Brazilian teaching hospital. Additionally, we identified a previously unrecognized outbreak caused by a persistent azole-resistant () clone in the intensive care unit (ICU), correlating it with the main clinical data from the patients with invasive candidiasis. The molecular identification of the isolates was carried out by PCR-RFLP assay; antifungal susceptibility and biofilm formation were also evaluated. The genotyping of all () was performed by microsatellite analysis and the presence of mutations was assessed in the azole non-susceptible isolates. Fourteen () isolates were recovered from patients with invasive candidiasis, eight being fluconazole and voriconazole-resistant, and two intermediate only to fluconazole (FLC). All non-susceptible isolates showed a similar pattern of biofilm formation with low biomass and metabolic activity. The A395T mutation in was detected exclusively among the azole-resistant isolates. According to the microsatellite analysis, all azole non-susceptible isolates from the adult ICU were clustered together indicating the occurrence of an outbreak. Regarding clinical data, all patients infected by the clonal non-susceptible isolates and none of the patients infected by the susceptible isolates had been previously exposed to corticosteroids (p = 0.001), while the remaining characteristics showed no statistical significance. The current study revealed the persistence of an azole non-susceptible clone with low capacity to form biofilm over two years in the adult ICU. These results reinforce the need of epidemiological surveillance and monitoring antifungal susceptibility of isolates in hospital wards.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290035 | PMC |
http://dx.doi.org/10.3389/fmicb.2018.02997 | DOI Listing |
Antibiotics (Basel)
August 2025
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Strada Faggiola 1, Gariga di Podenzano, 29027 Piacenza, Italy.
: Vancomycin-resistant enterococci (VRE) are significant nosocomial pathogens worldwide, potentially transmitted by food-producing animals and related products. This study investigates the epidemiological role of bovine raw milk in the transmission of VRE to humans. : Bulk milk samples were screened for gene presence using a multiplex PCR.
View Article and Find Full Text PDFAntibiotics (Basel)
July 2025
Department of Experimental and Clinical, University of Florence, 50100 Florence, Italy.
Background: Cefiderocol (FDC) presents challenges in antimicrobial susceptibility testing (AST). The reference standard is the broth microdilution (BMD) method with iron-depleted cation-adjusted Mueller-Hinton broth (ID-CAMHB). Still, it is cumbersome for routine clinical laboratory use, while variable accuracy has been reported with available commercial systems.
View Article and Find Full Text PDFMicrobiol Spectr
August 2025
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Unlabelled: We assessed the performance of the VITEK 2 AST-N439 card for susceptibility testing of novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations and colistin in carbapenem-non-susceptible gram-negative isolates. A total of 425 clinical isolates, including ( = 242), ( = 97), and ( = 86), were tested using VITEK 2, with broth microdilution as the reference standard. Minimum inhibitory concentrations were interpreted according to Clinical and Laboratory Standards Institute breakpoints.
View Article and Find Full Text PDFIndian J Med Microbiol
August 2025
Department of Microbiology, Assam University, Silchar, Cachar, Assam, India, 788011. Electronic address:
Purpose: Chromobacterium violaceum is an opportunistic environmental pathogen, which act as a potential source of antimicrobial resistance genes. Acquisition of such genes by non-susceptible organisms, aided by mobile genetic elements possess a serious clinical threat. With the rise and expansion of carbapenem resistance worldwide, the present study investigates two carbapenem non-susceptible Chromobacterium violaceum isolates through whole genome sequencing.
View Article and Find Full Text PDFJAC Antimicrob Resist
August 2025
Department of Emergency and Military Medicine, National Pirogov Memorial Medical University, Vinnytsia, Ukraine.
Background: is an important nosocomial pathogen worldwide. During the current invasion of Ukraine, reports of infections caused by this organism have proliferated. Here, we provide a phenotypic and genotypic analysis of associated with the conflict.
View Article and Find Full Text PDF